igf2 expression
Recently Published Documents


TOTAL DOCUMENTS

67
(FIVE YEARS 14)

H-INDEX

19
(FIVE YEARS 3)

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Rakan Naboulsi ◽  
Mårten Larsson ◽  
Leif Andersson ◽  
Shady Younis

AbstractThe expression of Igf2 in mammals shows a complex regulation involving multiple promoters and epigenetic mechanisms. We previously identified a novel regulatory mechanism based on the interaction between the transcriptional factor ZBED6 and Igf2 intron. Disruption of the ZBED6-Igf2 interaction leads to a dramatic up-regulation of IGF2 expression postnatally. In the current study we characterize an additional layer of regulation involving miR483 encoded by another Igf2 intron. We found a highly significant up-regulation of miR483 expression when the ZBED6-Igf2 axis is disrupted in transgenic mice. Furthermore, CRISPR/Cas9 mediated knock-out of miR483 in C2C12 myoblast cells, both wild-type and cells with disrupted ZBED6-Igf2 axis (Igf2dGGCT), resulted in down-regulation of Igf2 expression and a reduced proliferation rate. This was further validated using miR483 mimics and inhibitors. RNA-seq analysis revealed a significant enrichment of genes involved in the PI3K-Akt signaling pathway among genes down-regulated in miR483−/− cells, including Igf2 down-regulation. The opposite pattern was observed in Igf2dGGCT cells, where Igf2 is up-regulated. Our data suggest a positive feedback between miR483 and Igf2 promoter activity, strongly affecting how ZBED6 controls Igf2 expression in various cell types.


2021 ◽  
Author(s):  
Jihyun Jang ◽  
Guang Song ◽  
Qinshan Li ◽  
Xiaosu Song ◽  
Chenleng Cai ◽  
...  

AbstractRationalEstablishment of the myocardial wall requires proper growth cues from nonmyocardial tissues. During heart development, the epicardium and epicardium-derived cells (EPDCs) instruct myocardial growth by secreting essential factors including fibroblast growth factor 9 (FGF9) and insulin-like growth factor 2 (IGF2). However, it is poorly understood how the epicardial secreted factors are regulated, in particular by chromatin modifications for myocardial formation.ObjectiveTo understand whether and how histone deacetylase 3 (HDAC3) in the developing epicardium regulates myocardial growth.Methods and ResultsWe deleted Hdac3 in the developing murine epicardium and mutant hearts showed ventricular myocardial wall hypoplasia with reduction of EPDCs. The cultured embryonic cardiomyocytes with supernatants from Hdac3 knockout (KO) mouse epicardial cells (MECs) also showed decreased proliferation. Genome-wide transcriptomic analysis revealed that Fgf9 and Igf2 were significantly down-regulated in Hdac3 KO MECs. We further found that Fgf9 and Igf2 expression is dependent on HDAC3 deacetylase activity. The supplementation of FGF9 or IGF2 can rescue the myocardial proliferation defects treated by Hdac3 KO supernatant. Mechanistically, we identified that microRNA (miR)-322 and miR-503 were upregulated in Hdac3 KO MECs and Hdac3 epicardial KO hearts. Overexpression of miR-322 or miR-503 repressed FGF9 and IGF2 expression, while knockdown of miR-322 or miR-503 restored FGF9 and IGF2 expression in Hdac3 KO MECs.ConclusionsOur findings reveal a critical signaling pathway in which epicardial HDAC3 promotes compact myocardial growth by stimulating FGF9 and IGF2 through repressing miR-322/miR-503, providing novel insights in elucidating etiology of congenital heart defects, and conceptual strategies to promote myocardial regeneration.


2020 ◽  
Vol 10 (1) ◽  
Author(s):  
Hyang Sook Seol ◽  
Yoshimitsu Akiyama ◽  
San-Eun Lee ◽  
Shu Shimada ◽  
Se Jin Jang

AbstractStemness factors control microRNA expression in cancer stem cells. Downregulation of miR-100 and miR-125b is associated with tumor progression and prognosis of various cancers. Comparing miRNA profiling of patient-derived tumorsphere (TS) and adherent (2D) hepatocellular carcinoma cells, miR-100 and miR-125b are identified to have association with stemness. In TS cells, miR-100 and miR-125b were downregulated comparing to 2D cells. The finding was reproduced in Hep3B cells. Overexpression of stemness factors NANOG, OCT4 and SOX2 by introduction of gene constructs in Hep3B cells suppressed these two miRNA expression levels. Treatment of chromeceptin, an IGF signaling pathway inhibitor, decreased numbers of TS and inhibited the AKT/mTOR pathway. Stable cell line of miR-100 and miR-125b overexpression decreased IGF2 expression and inhibited tumor growth in the xenograft model. In conclusion, miR-100 and miR-125b have tumor suppressor role in hepatocellular carcinoma through inhibiting IGF2 expression and activation of the AKT/mTOR pathway.


Oncotarget ◽  
2020 ◽  
Vol 11 (44) ◽  
pp. 3904-3920
Author(s):  
Vinodh Kumar Radhakrishnan ◽  
Kameswaran Ravichandran ◽  
Chibuzo Eke ◽  
Amanda Ortiz-Vicil ◽  
Qianwei Tan ◽  
...  

2020 ◽  
Vol 81 (5) ◽  
pp. 766-775
Author(s):  
Andréia A. Suzukawa ◽  
Camila Zanluca ◽  
Natasha A.N. Jorge ◽  
Lucia de Noronha ◽  
Andrea C. Koishi ◽  
...  

2020 ◽  
Vol 9 (3) ◽  
pp. 357-365
Author(s):  
Maryam Salimi ◽  
Abolfazl Shirazi ◽  
Mohsen Norouzian* ◽  
Ameneh Jafari ◽  
Haleh Edalatkhah ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document